Overview
Hepatobiliary and pancreatic imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging
Current Appointments & Affiliations
Professor of Radiology
·
2022 - Present
Radiology, Abdominal Imaging,
Radiology
Professor in Medicine
·
2022 - Present
Medicine, Gastroenterology,
Medicine
Member of the Duke Cancer Institute
·
2016 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Performing liver imaging at a high level: quality and adequacy in LI-RADS.
Journal Article Abdom Radiol (NY) · June 2025 Imaging is critical to HCC management, including surveillance, diagnosis, staging, and treatment response assessment, which requires it be performed consistently at a high level. The Liver Imaging Reporting and Data System (LI-RADS) was developed to standa ... Full text Link to item CiteMRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort study.
Journal Article Eur Radiol · June 2025 OBJECTIVES: To develop and externally validate an MRI-based diagnostic model for microvascular invasion (MVI) or Edmondson-Steiner G3/4 (i.e., high-risk histopathology) in solitary BCLC 0/A hepatocellular carcinoma (HCC) ≤ 5 cm and to assess its performanc ... Full text Link to item CiteLarge Language Models for Diagnosing Focal Liver Lesions From CT/MRI Reports: A Comparative Study With Radiologists.
Journal Article Liver Int · June 2025 BACKGROUND & AIMS: Whether large language models (LLMs) could be integrated into the diagnostic workflow of focal liver lesions (FLLs) remains unclear. We aimed to investigate two generic LLMs (ChatGPT-4o and Gemini) regarding their diagnostic accuracies r ... Full text Link to item CiteRecent Grants
Evaluation of Efficacy, Safety and Tolerability of NGM282-PS-231 - NGM08
Clinical TrialPrincipal Investigator · Awarded by NGM Biopharmaceuticals, Inc. · 2024 - 2031Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Visceral Fat, Lipid Metabolites, and Liver Injury in Young Women
ResearchCo Investigator · Awarded by University of California - San Francisco · 2023 - 2028Genomic Imprinting in the Development of NAFLD
ResearchCollaborator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2028View All Grants
Education, Training & Certifications
University of Iowa ·
2004
M.D.